Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
3
|
pubmed:dateCreated |
1994-5-10
|
pubmed:abstractText |
The blood plasma levels of 5-fluorouracil (5FU) after i.v. administration have been determined without and under the influence of 1, 5 or 9 million units (MU) preadministered interferon (IFN) in patients with gastrointestinal carcinoma. The co-administration of 9 MU IFN causes a doubled increase of the 5FU serum concentrations combined with a statistically significant change of the pharmacokinetics of 5FU for c0, AUC, Vd and Cltot (P < 0.005). A similar effect with distinctly increased serum concentrations could be observed for the preadministration of 5 mU IFN whereby c0 and AUC were elevated significantly (P < 0.05), but not Vd, Cltot and cd. The preadministration of 1 MU IFN also leads to higher plasma levels, but no changes in the pharmacokinetics of 5FU could be calculated (P > 0.05). A linear correlation between the IFN dose and the pharmacokinetic parameters c0 (R = 0.958), AUC0-120 (R = 0.948), Vd (R = 0.941) and Cltot (R = 0.963) of 5FU could be found (P < 0.05), but not for the coefficient of distribution and t1/2el. The results indicate that the pharmacokinetics of 5FU might be influenced by the preadministered IFN dose.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:issn |
0378-7966
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
18
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
247-50
|
pubmed:dateRevised |
2011-11-17
|
pubmed:meshHeading |
pubmed-meshheading:8149941-Aged,
pubmed-meshheading:8149941-Antineoplastic Combined Chemotherapy Protocols,
pubmed-meshheading:8149941-Dose-Response Relationship, Drug,
pubmed-meshheading:8149941-Drug Administration Schedule,
pubmed-meshheading:8149941-Drug Interactions,
pubmed-meshheading:8149941-Female,
pubmed-meshheading:8149941-Fluorouracil,
pubmed-meshheading:8149941-Gastrointestinal Neoplasms,
pubmed-meshheading:8149941-Humans,
pubmed-meshheading:8149941-Interferon-alpha,
pubmed-meshheading:8149941-Liver Neoplasms,
pubmed-meshheading:8149941-Male,
pubmed-meshheading:8149941-Middle Aged,
pubmed-meshheading:8149941-Recombinant Proteins
|
pubmed:articleTitle |
Influence of different doses of interferon-alpha-2b on the blood plasma levels of 5-fluorouracil.
|
pubmed:affiliation |
Institute for Pharmaceutical Chemistry, University of Vienna, Austria.
|
pubmed:publicationType |
Journal Article,
Clinical Trial
|